TW258739B - - Google Patents
Info
- Publication number
- TW258739B TW258739B TW082102340A TW82102340A TW258739B TW 258739 B TW258739 B TW 258739B TW 082102340 A TW082102340 A TW 082102340A TW 82102340 A TW82102340 A TW 82102340A TW 258739 B TW258739 B TW 258739B
- Authority
- TW
- Taiwan
- Prior art keywords
- radical
- direct linkage
- formula
- cyclo
- hetero
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000005842 heteroatom Chemical group 0.000 abstract 3
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical group O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 125000004429 atom Chemical group 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 230000007935 neutral effect Effects 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical group OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000001118 alkylidene group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- -1 aromatic amino acid Chemical class 0.000 abstract 1
- 125000003968 arylidene group Chemical group [H]C(c)=* 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- FXHCFPUEIDRTMR-UHFFFAOYSA-N hydron;1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid;chloride Chemical group Cl.C1=CC=C2CNC(C(=O)O)CC2=C1 FXHCFPUEIDRTMR-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/18—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Transceivers (AREA)
- Mobile Radio Communication Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4211406 | 1992-04-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW258739B true TW258739B (enEXAMPLES) | 1995-10-01 |
Family
ID=6456125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW082102340A TW258739B (enEXAMPLES) | 1992-04-04 | 1993-03-30 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5597803A (enEXAMPLES) |
| EP (1) | EP0564972B1 (enEXAMPLES) |
| JP (1) | JP3426639B2 (enEXAMPLES) |
| KR (1) | KR100273825B1 (enEXAMPLES) |
| CN (1) | CN1040330C (enEXAMPLES) |
| AT (1) | ATE183197T1 (enEXAMPLES) |
| AU (1) | AU667707B2 (enEXAMPLES) |
| BR (1) | BR9301436A (enEXAMPLES) |
| CA (1) | CA2093305A1 (enEXAMPLES) |
| CZ (1) | CZ285698B6 (enEXAMPLES) |
| DE (1) | DE59309726D1 (enEXAMPLES) |
| DK (1) | DK0564972T3 (enEXAMPLES) |
| ES (1) | ES2136626T3 (enEXAMPLES) |
| FI (1) | FI931474A7 (enEXAMPLES) |
| GR (1) | GR3031543T3 (enEXAMPLES) |
| HU (1) | HU217613B (enEXAMPLES) |
| IL (1) | IL105287A (enEXAMPLES) |
| MX (1) | MX9301926A (enEXAMPLES) |
| NO (1) | NO311941B1 (enEXAMPLES) |
| NZ (1) | NZ247317A (enEXAMPLES) |
| PL (1) | PL175901B1 (enEXAMPLES) |
| RU (1) | RU2109747C1 (enEXAMPLES) |
| SK (1) | SK281970B6 (enEXAMPLES) |
| TW (1) | TW258739B (enEXAMPLES) |
| ZA (1) | ZA932399B (enEXAMPLES) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09511500A (ja) * | 1994-03-09 | 1997-11-18 | コーテック，インコーポレイティド | Ｎ−置換化グリシンを含むブラジキニン拮抗薬ペプチド |
| FR2739553B1 (fr) | 1995-10-06 | 1998-01-02 | Oreal | Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute |
| DE19612067A1 (de) * | 1996-03-27 | 1997-10-02 | Hoechst Ag | Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen |
| FR2790260B1 (fr) | 1999-02-26 | 2001-05-04 | Fournier Ind & Sante | Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique |
| RU2251433C2 (ru) * | 1999-04-29 | 2005-05-10 | Ново Нордиск А/С | Применение гепаринсвязывающих антагонистов в ингибировании высвобождения брадикинина |
| US7105172B1 (en) | 1999-11-18 | 2006-09-12 | Bolla John D | Treatment of rosacea |
| US6699486B1 (en) | 1999-11-18 | 2004-03-02 | Bolla Corporation | Treatment or prevention of photoaging and skin cancer |
| US20040248809A1 (en) * | 2003-02-07 | 2004-12-09 | Aventis Pharma Deutschland Gmbh | Use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis |
| SI21506A (sl) * | 2003-05-08 | 2004-12-31 | LEK farmacevtska dru�ba d.d. | Postopek za pripravo perindoprila |
| US20210238230A1 (en) | 2018-04-20 | 2021-08-05 | Fresenius Kabi Ipsum S.R.L. | A method for production of high purity icatibant |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4210584A (en) * | 1979-01-15 | 1980-07-01 | Eli Lilly And Company | Vindesine synthesis |
| US4350704A (en) * | 1980-10-06 | 1982-09-21 | Warner-Lambert Company | Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids |
| US4344949A (en) * | 1980-10-03 | 1982-08-17 | Warner-Lambert Company | Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids |
| US4374847A (en) * | 1980-10-27 | 1983-02-22 | Ciba-Geigy Corporation | 1-Carboxyalkanoylindoline-2-carboxylic acids |
| US4693993A (en) * | 1985-06-13 | 1987-09-15 | Stewart John M | Bradykinin antagonist peptides |
| US4923963A (en) * | 1987-09-02 | 1990-05-08 | Nova Technology Limited Partnership | Bradykinin antagonist peptides |
| EP0334244A3 (en) * | 1988-03-25 | 1991-05-29 | The Procter & Gamble Company | Bradykinin antagonist peptides |
| DE4013270A1 (de) * | 1990-04-26 | 1991-10-31 | Hoechst Ag | Peptide mit bradykinin-antagonistischer wirkung |
| IE63490B1 (en) * | 1988-11-24 | 1995-05-03 | Hoechst Ag | Peptides having bradykinin antagonist action |
| DE3926822A1 (de) * | 1989-08-14 | 1991-02-21 | Hoechst Ag | Peptide mit bradykinin-antagonistischer wirkung |
| EP0502987B1 (en) * | 1989-12-08 | 1994-08-31 | Trustees Of Boston University | Acylated bradykinin antagonists and uses therefor |
| MX9100717A (es) * | 1990-08-24 | 1992-04-01 | Syntex Inc | Antagonistas de la bradiquinina |
-
1993
- 1993-03-30 TW TW082102340A patent/TW258739B/zh active
- 1993-03-31 DE DE59309726T patent/DE59309726D1/de not_active Expired - Lifetime
- 1993-03-31 AT AT93105336T patent/ATE183197T1/de not_active IP Right Cessation
- 1993-03-31 ES ES93105336T patent/ES2136626T3/es not_active Expired - Lifetime
- 1993-03-31 EP EP93105336A patent/EP0564972B1/de not_active Expired - Lifetime
- 1993-03-31 DK DK93105336T patent/DK0564972T3/da active
- 1993-04-01 FI FI931474A patent/FI931474A7/fi unknown
- 1993-04-01 NZ NZ247317A patent/NZ247317A/en not_active IP Right Cessation
- 1993-04-02 SK SK289-93A patent/SK281970B6/sk unknown
- 1993-04-02 AU AU35651/93A patent/AU667707B2/en not_active Ceased
- 1993-04-02 NO NO19931287A patent/NO311941B1/no unknown
- 1993-04-02 RU RU93004822A patent/RU2109747C1/ru not_active IP Right Cessation
- 1993-04-02 MX MX9301926A patent/MX9301926A/es not_active IP Right Cessation
- 1993-04-02 CA CA002093305A patent/CA2093305A1/en not_active Abandoned
- 1993-04-02 PL PL93298362A patent/PL175901B1/pl not_active IP Right Cessation
- 1993-04-02 CZ CZ93572A patent/CZ285698B6/cs not_active IP Right Cessation
- 1993-04-02 ZA ZA932399A patent/ZA932399B/xx unknown
- 1993-04-02 JP JP07687793A patent/JP3426639B2/ja not_active Expired - Lifetime
- 1993-04-02 CN CN93103564A patent/CN1040330C/zh not_active Expired - Fee Related
- 1993-04-02 IL IL10528793A patent/IL105287A/en not_active IP Right Cessation
- 1993-04-02 HU HU9300972A patent/HU217613B/hu not_active IP Right Cessation
- 1993-04-03 KR KR1019930005632A patent/KR100273825B1/ko not_active Expired - Fee Related
- 1993-04-05 BR BR9301436A patent/BR9301436A/pt not_active Application Discontinuation
-
1995
- 1995-01-17 US US08/373,464 patent/US5597803A/en not_active Expired - Lifetime
-
1999
- 1999-10-15 GR GR990402630T patent/GR3031543T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE465222C5 (sv) | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning | |
| TW258739B (enEXAMPLES) | ||
| DE69627704D1 (en) | Protegrine | |
| ES526201A0 (es) | Un procedimiento para preparar un peptido que tiene influencia sobre la funcion de la glandula pituitaria | |
| SE9100799L (sv) | Rekombinant derivat av human faktor viii | |
| DE69429176D1 (en) | Protegrine | |
| DK413986D0 (da) | Syntetisk peptid og farmaceutisk middel indeholdende peptidet | |
| KR870007203A (ko) | 펩타이드를 제조하는 방법 | |
| RU93004822A (ru) | Пептиды, способ их получения, содержащее их лекарственное средство | |
| ATE45165T1 (de) | Reduzierte peptide, hemmungsstoffe gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ATE30919T1 (de) | Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel. | |
| EP0249394A3 (en) | Small peptides wich inhibit binding to t-4 receptors and act as immunogens | |
| DE68905097D1 (de) | Peptid-molekuele, wirksam gegen gram-positive keime. | |
| RU96118282A (ru) | Пептиды для ингибирования высвобождения пепсина | |
| KR890002233A (ko) | 혈관이완, 나트륨이뇨 및 이뇨효과가 있는 펩타이드 | |
| KR890002234A (ko) | 혈관확장, 나트륨배설 및 이뇨활성을 지니는 펩타이드, 이의 제조방법, 이를 함유하는 제제, 및 이의 용도 |